SCHEMBL1784097

SCHEMBL1784097

O=P(c1ccccc1)(c1ccccc1)c1ccccc1Br

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.44
ALDH1A1 P00352 3/20 0.44
NPSR1 Q6W5P4 2/20 0.44
HTT P42858 2/20 0.44
KMT2A Q03164 4/20 0.44
MEN1 O00255 2/20 0.44
CA2 P00918 1/20 0.41
CA4 P22748 1/20 0.41
CA5A P35218 1/20 0.41
APOBEC3A P31941 1/20 0.39
CASP6 P55212 1/20 0.39
CTDSP1 Q9GZU7 1/20 0.39
APOBEC3G Q9HC16 1/20 0.39
LMNA P02545 1/20 0.38
CFTR P13569 1/20 0.37
MAPT P10636 2/20 0.37
KDM4E B2RXH2 1/20 0.37
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20345791 0.87 KMT2A (0.43) POLBALDH1A1NPSR1HTTKMT2A
SCHEMBL22159501 0.84 NPSR1 (0.42) POLBALDH1A1NPSR1HTTKMT2A
SCHEMBL4762963 0.83 POLB (0.52) POLBALDH1A1NPSR1HTTKMT2A
SCHEMBL22831337 0.80 NPSR1 (0.39) POLBALDH1A1NPSR1HTTKMT2A
SCHEMBL27989375 0.79 KMT2A (0.50) POLBALDH1A1NPSR1HTTKMT2A
SCHEMBL14552277 0.78 CA2 (0.38) POLBALDH1A1NPSR1HTTKMT2A
SCHEMBL23600021 0.77 CA1 (0.32) ALDH1A1NPSR1KMT2AMEN1CA2
SCHEMBL28530782 0.77 KMT2A (0.44) POLBALDH1A1NPSR1HTTKMT2A
SCHEMBL14020795 0.76 NPSR1 (0.52) POLBALDH1A1NPSR1HTTKMT2A
SCHEMBL134314 0.76 POLB (0.47) POLBALDH1A1NPSR1HTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111406059-B Europium complexes 东曹株式会社 2023-04-18 CN disclosed
US-20220064197-A1 PHOSPHINE OXIDE GROUP-CONTAINED TRANSITION METAL COMPLEX, AND POLYMER, MIXTURE, COMPOSITION, AND ORGANIC ELECTRONIC DEVICE THEREOF GUANGZHOU CHINARAY OPTOELECTRONIC MATERIALS LTD. (CN) 2022-03-03 US disclosed
US-10988494-B2 Europium complex TOSOH CORPORATION (JP) 2021-04-27 US disclosed
US-20200354389-A1 EUROPIUM COMPLEX SAGAMI CHEMICAL RESEARCH INSTITUTE (JP) 2020-11-12 US disclosed
CN-111406059-A Europium complexes 东曹株式会社 2020-07-10 CN disclosed
WO-2020125589-A1 PHOSPHINE OXIDE GROUP-CONTAINED TRANSITION METAL COMPLEX, AND POLYMER, MIXTURE, COMPOSITION, AND ORGANIC ELECTRONIC DEVICE THEREOF 广州华睿光电材料有限公司 2020-06-25 WO disclosed
EP-3281238-A1 SEMICONDUCTING MATERIAL COMPRISING A PHOSPHINE OXIDE MATRIX AND METAL SALT Novaled GmbH (DE) 2018-02-14 EP disclosed
EP-2212339-B1 BIDENTATE CHIRAL LIGANDS FOR USE IN CATALYTIC ASYMMETRIC ADDITION REACTIONS SOLVIAS AG (CH) 2018-01-10 EP disclosed
CN-107226827-A A kind of preparation method of chiral phosphorus fluorenes oxide 杭州师范大学 2017-10-03 CN disclosed
US-20170194576-A1 Transition Metal Complexes with Tripodal Ligands and the Use Thereof in OLEDs UDC IRELAND LIMITED (IE) 2017-07-06 US disclosed
US-20170194576-A1 Transition Metal Complexes with Tripodal Ligands and the Use Thereof in OLEDs UDC IRELAND LIMITED (IE) 2017-07-06 US disclosed
US-8598371-B2 Bidentate chiral ligands for use in catalytic asymmetric addition reactions SOLVIAS AG (CH) 2013-12-03 US disclosed
US-20130267714-A1 BIDENTATE CHIRAL LIGANDS FOR USE IN CATALYTIC ASYMMETRIC ADDITION REACTIONS SOLVIAS AG (CH) 2013-10-10 US disclosed
US-8450501-B2 Bidentate chiral ligands for use in catalytic asymmetric addition reactions SOLVIAS AG (CH) 2013-05-28 US disclosed
US-20110118482-A1 BIDENTATE CHIRAL LIGANDS FOR USE IN CATALYTIC ASYMMETRIC ADDITION REACTIONS SOLVIAS AG 2011-05-19 US disclosed
EP-2212339-A1 BIDENTATE CHIRAL LIGANDS FOR USE IN CATALYTIC ASYMMETRIC ADDITION REACTIONS Solvias AG (CH) 2010-08-04 EP disclosed
WO-2009065784-A1 BIDENTATE CHIRAL LIGANDS FOR USE IN CATALYTIC ASYMMETRIC ADDITION REACTIONS SOLVIAS AG (CH) 2009-05-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10988494-B2 Europium complex SSB, XPA, UACA POLB 2679/4885ALDH1A1 3892/4885NPSR1 3070/4885
US-20200354389-A1 EUROPIUM COMPLEX SSB, XPA, UACA POLB 2679/4885ALDH1A1 3892/4885NPSR1 3070/4885
US-20170194576-A1 Transition Metal Complexes with Tripodal Ligands and the Use Thereof in OLEDs TRPM2, OCIAD2, TRPM6 POLB 2756/4885ALDH1A1 1748/4885NPSR1 1540/4885
US-20130267714-A1 BIDENTATE CHIRAL LIGANDS FOR USE IN CATALYTIC ASYMMETRIC ADDITION REACTIONS C1R, PNISR, CBR1 POLB 279/4885ALDH1A1 2792/4885NPSR1 219/4885
US-20220064197-A1 PHOSPHINE OXIDE GROUP-CONTAINED TRANSITION METAL COMPLEX, AND POLYMER, MIXTURE, COMPOSITION, AND ORGANIC ELECTRONIC DEVICE THEREOF PHOSPHO1, CPNE4, TCP1 POLB 723/4885ALDH1A1 4298/4885NPSR1 3747/4885
US-20110118482-A1 BIDENTATE CHIRAL LIGANDS FOR USE IN CATALYTIC ASYMMETRIC ADDITION REACTIONS H1-2, H1-0, C1R POLB 112/4885ALDH1A1 3555/4885NPSR1 382/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.